AMA Update Welcome to the AMA COVID-19 Update
Get your news from the physicians, scientists and others leading the pandemic response. Subscribe now on your favorite podcast platform.
Read MorePodcast: AMA Update
AMA Update 148: The latest from the FDA on second booster shots and more with Susan R. Bailey, MD
AMA CXO Todd Unger chats with AMA’s immediate past president, Susan Bailey, MD, about big takeaways from her recent conversation with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research at the FDA. Their talk covered COVID-19 second dose boosters and pediatric vaccines.
Read MoreAMA Update 147: FDA’s latest on J&J vaccine safety concerns and more with Andrea Garcia, JD, MPH
AMA CXO Todd Unger discusses the latest Johnson & Johnson COVID vaccine news with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering a newly released estimate for COVID-19 related deaths using excess mortality, as well as summer spikes of coronavirus cases, hospitalizations, and that masking up in airports or high-risk settings continues to reduce chances of COVID infection.
Read MoreAMA Update 146: FDA to review COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH
AMA CXO Todd Unger reviews the latest timeline on Moderna and Pfizer vaccine authorizations for young children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the rise in COVID cases, FDA’s proposed timing to review data on Novavax and variant-specific vaccines, as well as how to spot fake COVID-19 at-home tests.
Read MoreAMA Update 145: Four physicians discuss moving beyond the COVID-19 pandemic
How will our nation—and America’s physicians—move beyond this pandemic? Tune in to hear expert physician perspectives on what lies ahead—and to learn how to prepare yourself, your practice and your patients for what’s next. Our physician guests include: Georges Benjamin, MD, Executive director, American Public Health Association; Céline Gounder, MD, Senior fellow and editor-at-large for Public Health, Kaiser Family Foundation and Kaiser Health News; clinical associate professor, Medicine and Infectious Diseases, New York University; Stephen Parodi, MD, executive vice president, External Affairs, Communications, and Brand, The Permanente Federation; associate executive director, The Permanente Medical Group
Read MoreAMA Update 144: Marcus Plescia, MD, MPH, on changes in COVID data reporting & more
AMA CXO Todd Unger discusses COVID data reporting changes and strengthening public health infrastructure with Marcus Plescia, MD, MPH, the chief medical officer of the Association of State and Territorial Health Officials (ASTHO) in Atlanta.
Read MoreAMA Update 143: Mask mandates & FDA approves Remdesivir for kids under 12 with Andrea Garcia, JD, MPH
AMA CXO Todd Unger reviews COVID-19 case numbers and the legal battle over mask mandates with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the CDC’s latest health alert for COVID therapies, as well as the FDA’s approval of Remdesivir to treat pediatric coronavirus patients (kids 12 and younger).
More information on the CDC’s health alert: https://emergency.cdc.gov/han/2022/han00463.asp
Read MoreAMA Update 142: Which airlines and public transit require masks with Andrea Garcia, JD, MPH
AMA CXO Todd Unger reviews changes to the national mask mandate with AMA Director of Science, Medicine and Public Health Andrea Garcia, including which airlines no longer require masks and the cities still enforcing mask mandates on public transit. Also covering the emerging subvariants BA.2.12 and BA.2.12.1, a new COVID breath test, and why Americans over 60 should get a second booster shot.
Read MoreAMA Update 141: Lessons from the pandemic with Tom Frieden, MD, MPH
AMA CXO Todd Unger is joined by Tom Frieden, MD, MPH, former director of the CDC and president and CEO of Resolve to Save Lives in New York to discuss how we can use lessons from the past two years to strengthen our public health system and pandemic response.
Read MoreAMA Update 140: Vaccine trials ramp up for possible fourth dose in fall with Andrea Garcia, JD, MPH
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA’s vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotrovimab to treat high-risk COVID-19 patients in the U.S. because it’s unlikely to be effective against BA.2, and a clinical trial published in NEJM confirms that the anti-parasitic drug, ivermectin, showed no sign of alleviating COVID.
Read More